Dr Michelle Wilson is a Medical Oncologist who subspecialises in gynaecological cancers and early-phase clinical trials. She is the clinical director for Cancer and Blood Research at Auckland City Hospital. Michelle is a very active researcher, and is also one of 4 PIs with the early phase Auckland Cancer Trials Centre. Her research focus is geared towards early phase translational studies and clinical trial endpoints, in particular their utility and evolution in the era of precision oncology. She was awarded a medical doctorate on this topic in 2018 through the University of Auckland. Michelle is an ANZGOG Board Director, Chair of the Ovarian Tumour Working Group, a member of the ANZGOG Research Advisory Committee and the OASIS Steering Committee.

Dr Janine Lombard has been conducting breast and gynaecological research in the Medical Oncology Research Department at Calvary Mater Newcastle since 2006. Her main interest is breast and gynaecological cancers and measures to improve both outcomes but also reduce the toxicities of treatments for these diseases. Dr Lombard is involved in basic translation research through links with researchers at HMRI and the University of Newcastle in breast and ovarian cancer. She has also been involved in several important trials in early and advanced breast cancer treatments, some of which have significantly changed clinical practice. Her involvement in the POEMS study helped to establish the use of a drug to protect fertility and prevent early menopause symptoms in women with estrogen negative early breast cancer.

Dr Lombard is currently a local principal investigator for several studies exploring new treatment options in relapsed (metastatic) breast cancer, ovarian and endometrial cancer. In gynaecological cancer she is principal investigator for a number of Australian and international studies of new treatments in ovarian cancer. She is an active member of ANZGOG and the Chair Elect of the Uterine Tumour Working Group. In early drug research she is principal investigator for a phase 1B study exploring new drug compounds in several tumour subtypes.

Associate Professor Jeffrey Goh is an experienced medical oncologist and Adjunct Professor at Queensland University of Technology (QUT). He consults and treats patients at Icon Cancer Centre Chermside and Icon Cancer Centre Greenslopes. A/Prof Goh maintains a significant part-time role as senior staff specialist at Royal Brisbane & Women’s Hospital (RBWH). He sits on the ANZGOG Research Advisory Committee and is the past Chair of ANZGOG’s Cervical Cancer Tumour Working Group and a past Board Director. He is co-supervisor of PhD candidates at the University of Queensland and was previously a senior lecturer. A/Prof Goh is also involved with mentoring advanced trainee registrars in medical oncology at RBWH. Additionally, A/Prof Goh is a member of Icon’s Research Committee and Medical Advisory Committee (MAC). His past clinical experience covers a broad range of solid tumour malignancies, however, he has a special clinical and research interest in gynaecological and genitourinary malignancies (which he focuses on), in addition to phase I/Ib clinical trials.

Prof Paul Cohen is a clinician-researcher at the Western Australian Gynaecological Cancer Service, King Edward Memorial Hospital. He is a Clinical Professor at the University of Western Australia and Adjunct Professor at the Institute for Health Research, University of Notre Dame Australia. Prof Cohen is an Investigator on national and international clinical trials and has particular interests in the supportive care of women affected by cancer, and gynaecological cancer epidemiology.

Prof Cohen is the new Chair of the ANZGOG Research Advisory Committee, past Chair of the ANZGOG ASM Program Committee, and is a member of the eviQ Cancer Genetics Reference Committee, National Gynaecological Oncology Registry Steering Committee, and Australian Clinical Trial Alliance Impact and Implementation Committee. He is the current Chair of the International Gynecological Cancer Society Education Committee and a member of the Editorial Board of the International Journal of Gynaecological Cancer.

Dr Lois Eva is the Director of Gynaecological Oncology in Auckland, Honorary Senior Lecturer with the University of Auckland and heads the regional Vulval service.

She holds a MD in vulval disease and has published extensively on vulval cancers and precancers, and has supervised projects in vulval cancer for Masters and MD students.   She became a Fellow of the International Society for the Study of Vulvovaginal Disease (ISSVD) in 2003, is a member of the ISSVD Post Graduate teaching Course faculty and is an editorial board member of the Journal of Lower Genital Tract Disease. She is the current Vice President of the ASCCP and teaches on vulval disease at their courses.

She has extensive experience in vulval surgery and recently presented in the IGCS film festival on vulval cancer resection and reconstruction.  She is a co-author of the vulval chapter for the IGCS Global Nursing Curriculum.

Professor Nicklin is a graduate of the University of Queensland. He did his internship and residency at the Royal Brisbane and Royal Women’s Hospitals. He subsequently went on to do specialty training in obstetrics and gynaecology in Queensland. He then did his sub-specialty training in gynaecologic oncology at the Royal Hospital for Women in Sydney and the Ohio State University, USA. He returned to Queensland and set up practice as a gynaecologic oncologist in late 1995. He is currently a Professor of Gynaecologic Oncology at University of Qld, a past Director of Gynaecologic Oncology at RBWH, a past Chairperson of Australian Society of Gynaecologic Oncologists (ASGO), a member of ANZGOG, the inaugural and immediate past Chair of the Western Pacific Gynaecological Oncology Liaison Group and now retired from clinical practice. He has a particular interest in medical aid work and is an International Gynaecologic Cancer Society mentor to the clinicians in the Western Pacific.

Assc prof Peter Sykes is a gyn oncologist working in Christchurch and a clinical academic working with the University of Otago. He has a long standing research interest in gynaecological cancer and author on over 100 research publications. He is lead investigator on the Australian and New Zealand sentinel node audit for women with vulval cancer. He is the immediate past chair of ASGO and a former ANZGOG board and RAC member.

Associate Professor Emma Allanson is a consultant gynaecological oncologist with a full time public appointment at King Edward Memorial Hospital in Perth, Western Australia. She has academic appointments at the University of Western Australia and the University of Notre Dame. Emma has a Masters in Public Health and a PhD in global women’s health. In addition to having lived and worked in South Africa in 2014, Emma worked as a consultant in 2015 in Geneva for WHO in the Department of Reproductive Health and Research (RHR), and has undertaken a research fellowship in the global prevention of cervical cancer with Dr Kathleen Schmeler at MD Anderson Cancer Centre (Houston, Texas) in 2020. Emma’s current research activity includes work with colleagues in Vanuatu on cervical cancer screening and colleagues across Africa and the USA assessing available cervical cancer treatment in Africa. Emma is a member of the ANZGOG cervical cancer working group, and sat on the ANZGOG 2023 ASM Program Steering Committee and co-chaired the ANZGOG Endometrial Cancer Preceptorship last year.

Dr Rosie is specialist Obstetrician and Gynaecologist completing subspecialisation in Gynae Oncology at the Royal Women’s Hospital in Melbourne. Her current research interests include the management and molecular biology of gynaecological malignancies.

Bio coming soon…

Dr Ming-Yin Lin is a Gynaecological Radiation Oncologist at Peter MacCallum Cancer Centre since 2015 , where she is currently also the Director of Radiation Oncology Training (Parkville Campus).

Dr Lin graduated from the University of Melbourne in 2006 and completed specialist training at the Peter MacCallum Cancer Centre where she subsequently undertook a clinical and research fellowship in Gynae-Oncology and Image Guided Brachytherapy. She is actively involved in clinical research in gynaecological cancers and has a specific interest in image guided brachytherapy in the treatment of cervix, endometrial and vulvo-vaginal cancers. She presents regularly at local and international conferences and has numerous peer-reviewed publications.

Dr Lin is an active member of ANZGOG and currently serving as Chair of ANZGOG’s Cervical- Vulvo Vagina Cancer Tumour Working Group ( CVVTWG ) and a member of the Research Advisory Committee. She is also heavily involved in the teaching of trainees in gynae-oncology and radiation oncology through International Gynaecologic Cancer Society (IGCS) , Australian Brachytherapy Group (ABG) and Royal Australian New Zealand College of Radiologist (RANZCR).

Dr Ruth Angell is a radiation oncologist currently working at the Regional Cancer Service, Auckland City Hospital and Auckland Radiation Oncology.  She is the tumour lead for the radiation oncology gynae team at Auckland. Dr Angell has a special interest in breast, colorectal, gastrointestinal and gynaecological cancers.  She is a member of the National Breast Cancer Special Interest Group, the New Zealand Gynaecological Cancer Group and the National Gastrointestinal Special Interest Group. Dr Angell has worked in oncology in the United Kingdom and in Australia.  She trained at the Peter MacCallum Cancer Centre in Melbourne and at Auckland City Hospital.  Dr Angell is a dedicated oncologist and a strong advocate for her patients.

Robyn Cheuk is a Radiation Oncologist with Royal Brisbane and Women’s Hospital in Queensland, where she works as physician and examiner. A radiation oncologist with 35 years of experience in the field, she also acts as Senior Lecturer for the School of Medicine at the University of Queensland in Brisbane, Queensland. Highly active in her field, Dr Cheuk is on staff at several local facilities, including Mater Cancer Care Centre in South Brisbane and Mater Children’s Private Brisbane, and speaks locally to colleagues on healthcare. Furthermore, Dr Cheuk is a Fellow of Royal Australian and New Zealand College of Radiologists. Throughout her many years of experience, she has upheld a steadfast commitment to the ethical and professional standards of her practice, as evidenced by her sterling record, and ensures an impeccable degree of patient satisfaction in all facets of her work.

Professor Marion Saville AM is Executive Director of the Australian Centre for the Prevention of Cervical Cancer since 2000. Marion has served on cervical screening advisory committees in Australia, New Zealand and Ontario. She currently chairs the working group to review Australia’s Guidelines for the management of screen-detected abnormalities in the National Cervical Screening Program.

Associate Professor Lyndal Anderson is a medical graduate of the University of Tasmania and commenced Pathology training in England in 2000. In Australia she trained at St Vincent’s Hospital Sydney and the Royal Prince Alfred Hospital before completing her Fellowship from the Royal College of Pathologists of Australasia in 2005. She completed a Master of Philosophy in Gynaecological Pathology with The University of Sydney in 2011 and a Masters of Health Management with The University of New South Wales in 2012.

Assoc Prof Anderson’s primary interests include Gynaecological Pathology and Cytopathology. She is a Senior Staff Specialist at Royal Prince Alfred Hospital, an Associate Professor at Western Sydney University, and an Associate Professor at The University of Sydney. She is a member of the Research Advisory Committee for ANZGOG, a member of the Translational Research ANZGOG committee, and is the current President of the Australian Society of Cytology.

Ms Nicole Kinnane is a project manager (Australian Cancer Survivorship Centre) and a nationally recognised, specialist gynae-oncology nurse with expertise in cancer survivorship working as a nurse consultant in the gynae-oncology service at Peter MacCallum Cancer Centre.  Nicole has a demonstrated track record of generating and implementing evidence for multidisciplinary cancer and cross sector survivorship care. She has submitted her thesis for Master of Philosophy at Melbourne University. The thesis examined the patterns of follow up and disease outcomes for women treated for endometrial cancer over a 10-year period and explored experiences of follow up via interviews. Nicole’s portfolio for the Australian Cancer Survivorship Centre includes health care professional and consumer education, implementation of survivorship initiatives in the clinical setting, and development of health professional and consumer survivorship resources and tools. Nicole is committed to improving the outcomes for patients diagnosed with cancer and their families during and after treatment. Her dual roles allow her to implement survivor care recommendations in the clinical setting. Her career objective is to improve outcomes and experiences of cancer survivors through a dedicated nurse clinician-researcher role.

Bio coming soon…

Bree Stevens is ANZGOG’s Survivors Teaching Students® (STS) Program Manager. STS is a sought-after experiential learning program that brings gynaecological cancer survivors and caregivers into the classrooms of our next generation of health professionals to teach them about women’s experience with the diseases. Working with over 100 active volunteers, Bree trains and supports STS presenters to share their stories and help students understand the ‘lived experience’ of a gynaecological cancer, including the psychosocial impact, and the importance of timely diagnosis, good health communication and compassionate care.

Norma Raspin as a vulvar cancer survivor from the Tasmanian team of ANZGOG’s Survivors Teaching Students (STS) Program. Based in North-West Tasmania, Norma is passionate about sharing her story with our next generation of health professionals through STS to ensure they have not only an awareness of gynaecological cancers but an understanding of the lived experience and the importance of good communication and compassionate care to take into their future practice.